Iurlo, Alessandra <br/><br/>
Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients.  [electronic resource] 

 -  European journal of internal medicine  Jan 2014 
 - 63-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0828 
<br/><br/><label>Standard No.: </label>10.1016/j.ejim.2013.11.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides--therapeutic use<br/>Cohort Studies<br/>Comorbidity<br/>Drug Interactions<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Piperazines--therapeutic use<br/>Polypharmacy<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrimidines--therapeutic use<br/>Retrospective Studies<br/>Treatment Outcome